Top results
1. idh mutations in gliomas bryden dawes 2. section title sub heading idh mutations in gliomas © 2015 macquarie neurosurgery - confidential (copyright text) 3. section title…
idh-1 immunohistochemistry in glioma diagnosis kieren allinson lecture plan classification of brain tumours grading of common gliomas idh-1 mutations in glioblastoma mutation-specific…
doi: 101126scitranslmed3002693 116ra4 20124 sci transl med et alovidiu c andronesi spectroscopy vivo spectral-editing and 2d correlation magnetic resonance -mutated glioma…
review glioma subclassifications and their clinical significance ricky chen1 matthew smith-cohn1 adam l. cohen2 howard colman3 published online: 9 march 2017 # the american…
005 co-occurrence of atrx and idh mutations identify.cdrsummary in gliomas, with idh mutational status, atrx loss of protein classified diffuse astrocytic low grade and primary
module3_levis_ashaml2019_v11simark levis, md, phd director, adult leukemia program co-division director, hematologic malignancies professor of oncology the sidney kimmel
hindawi publishing corporation journal of drug delivery volume 2013, article id 529312, 9 pages http://dx.doi.org/10.1155/2013/529312 review article cancer epigenetics: new
glioma: state of the art approach m.j. van den bent the brain tumor center at erasmus mc cancer center rotterdam, the netherlands do no t du plic ate or dis trib ute wi tho…
research article megf10, a glioma survival-associated molecular signature, predicts idh mutation status guanzhang li,1,2 zhiliang wang,1,2 chuanbao zhang,2 xing liu,1,2 fuqiang…
1scientific reports 5:13895 doi: 101038srep13895 wwwnaturecomscientificreports autoantibody profiling of glioma serum samples to identify biomarkers using human proteome…
the role of idh inhibitors in hematologic malignancies the role of idh inhibitors in hematologic malignancies aml what is it and how did it get there? key points from de…
1 title: idh1 mutations induce organelle defects via dysregulated phospholipids 1 adrian lita1 artem pliss2 andrey kuzmin23 tomohiro yamasaki1 lumin zhang1 tyrone 2 dowdy1…
review series the journal of clinical investigation http:www.jci.org volume 123 number 9 september 2013 3659 detection of oncogenic idh1 mutations using magnetic resonance…
© the authors 2018. published by oxford university press on behalf of the society for neuro-oncology. neuro-oncology 2011, 1505–1516, 2018 doi:10.1093neuoncnoy088 advance…
normal cellular differentiation cells with idh mutations isocitrate dehydrogenase mutations idhm and their role in idhm-positive cancers understanding mutations in idh an…
wang et al., sci. adv. 2020 6 : eaaz3221 22 april 2020 s c i e n c e a d v a n c e s r e s e a r c h a r t i c l e 1 of 13 g e n e t i c s targeting therapeutic vulnerabilities…
integrative genomic characterization of lower grade gliomas daniel j. brat md, phd emory university school of medicine on behalf of the tcga lower grade gliomas analysis…
www.aging-us.com 673 aging introduction diffuse gliomas, graded from ii to iv according to the world health organization who criteria, are the most common and lethal primary…
intrahepatic cholangiocarcinoma: novel genetic signatures and therapeutic targets andrew x. zhu, md, phd 2nd international conference on phase 1 and early phase clinical…